ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina)

MeSH terms

• Abciximab
• Angina, Unstable / blood
• Angina, Unstable / complications
• Angina, Unstable / therapy*
• Angioplasty, Balloon, Coronary
• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal / therapeutic use
• Anticoagulants / adverse effects
• Anticoagulants / therapeutic use
• Biomarkers / blood
• Clopidogrel
• Disease Management
• Drug Therapy, Combination
• Electrocardiography*
• Eptifibatide
• Female
• Health Behavior
• Hemorrhage / etiology
• Humans
• Hypolipidemic Agents / adverse effects
• Hypolipidemic Agents / therapeutic use
• Immunoglobulin Fab Fragments / adverse effects
• Immunoglobulin Fab Fragments / therapeutic use
• Male
• Myocardial Infarction / blood
• Myocardial Infarction / complications
• Myocardial Infarction / therapy*
• Peptides / adverse effects
• Peptides / therapeutic use
• Platelet Aggregation Inhibitors / adverse effects
• Platelet Aggregation Inhibitors / therapeutic use
• Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
• Randomized Controlled Trials as Topic / statistics & numerical data
• Risk Assessment
• Risk Factors
• Ticlopidine / adverse effects
• Ticlopidine / analogs & derivatives
• Ticlopidine / therapeutic use
• Tirofiban
• Tyrosine / adverse effects
• Tyrosine / analogs & derivatives*
• Tyrosine / therapeutic use